SEARCH

SEARCH BY CITATION

References

  • 1
    Molmenti EP, Marsh JW, Dvorchik I, Oliver JH 3rd, Madariaga J, Iwatsuki S. Hepatobiliary malignancies. Primary hepatic malignant neoplasms. Surg Clin North Am 1999; 79:4357.
  • 2
    Hodgson HJF. Primary hepatocellular carcinoma. In: BlumgartLH, ed. Surgery of the Liver and Biliary Tract. Vol 2. 2nd ed. Edinburgh: Churchill Livingstone; 1994:13411363.
  • 3
    Beasley RP. Hepatitis B virus as the etiologic agent in hepatocellular carcinoma: Epidemiologic considerations. Hepatology 1982; 2:21S.
  • 4
    Kew MC. The hepatitis-B virus and hepatocellular carcinoma. Semin Liver Dis 1981; 1:5967.
  • 5
    Szmuness W. Hepatocellular carcinoma and the hepatitis B virus: Evidence for a causal association. Prog Med Virol 1978; 24:4069.
  • 6
    Larouze B, Saimot G, Lustbader ED, London WT, Werner BG, Payet M. Host responses to hepatitis-B infection in patients with primary hepatic carcinoma and their families. A case/control study in Senegal, West Africa. Lancet 1976; 2:534538.
  • 7
    Kew MC. Hepatitis C virus and hepatocellular carcinoma. FEMS Microbiol Rev 1994; 14:211219.
  • 8
    Eggel H. Uber das primare carcinom de leber. Beitr Pathol Anat 1901; 30:506604.
  • 9
    Peters RL. Pathology of hepatocellular carcinoma. In: OkudaK, PetersRL, eds. Hepatocellular Carcinoma. New York: John Wiley & Sons; 1976:107.
  • 10
    Deprez C, Vangansbeke D, Fastrez R, Pasteels JL, Verhest A, Kiss R. Nuclear DNA content, proliferation index, and nuclear size determination in normal and cirrhotic liver, and in benign and malignant primary and metastatic hepatic tumors. Am J Clin Pathol 1993; 99:558565.
  • 11
    Ezaki T, Kanematsu T, Okamura T, Sonoda T, Sugimachi K. DNA analysis of hepatocellular carcinoma and clinicopathologic implications. Cancer 1988; 61:106109.
  • 12
    Molmenti EP, Klintmalm GB. Cancer and liver transplantation. Transplantation Reviews 2000; 14:183198.
  • 13
    Dusenbery D, Dodd GD 3rd, Carr BI. Percutaneous fine-needle aspiration of portal vein thrombi as a staging technique for hepatocellular carcinoma. Cytologic findings of 46 patients. Cancer 1995; 75:20572062.
  • 14
    Dumortier J, Lombard-Bohas C, Valette PJ, Boillot O, Scoazec JY, Berger F, Claudel-Bonvoisin S. Needle tract recurrence of hepatocellular carcinoma after liver transplantation. Gut 2000; 47:301.
  • 15
    Molmenti EP, Klintmalm GB. Hepatocellular cancer in liver transplantation. J Hepatobiliary Pancreat Surg 2001; 8:427434.
  • 16
    Reyes JD, Carr B, Dvorchik I, Kocoshis S, Jaffe R, Gerber D, et al. Liver transplantation and chemotherapy for hepatoblastoma and hepatocellular cancer in childhood and adolescence. J Pediatr 2000; 136:795804.
  • 17
    Langnas AN, Shaw BW, Jr. Surgical therapy for hepatocellular carcinoma. In: SchiffER, SorrellMF, MaddreyWC, eds. Schiff's Diseases of the Liver. 8th ed. Philadelphia: Lippincott-Raven; 1999:13051317.
  • 18
    Huffman GR, Uzar A, Gorgulu S, et al. Preoperative needle biopsy and long-term outcome of patients undergoing resection for hepatocellular carcinoma. Presented at the 48th Annual Meeting of the American Association for the Study of Liver Diseases, November 7–11, 1997, Chicago, IL.
  • 19
    Okuda K, Okuda H. Primary liver cell carcinoma. In: McIntyreN, BenhamouJ-P, BircherJ, RizzettoM, RodesJ, eds. Oxford Textbook of Clinical Hepatology. Volume 2. Oxford, England: Oxford University Press; 1991:10191052.
  • 20
    Barbara L, Benzi G, Gaiani S, Fusconi F, Zironi G, Siringo S, et al. Natural history of small untreated hepatocellular carcinoma in cirrhosis: A multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology 1992; 16:132137.
  • 21
    Utsunomiya T, Matsumata T, Adachi E, Honda H, Sugimachi K. Limitations of current preoperative liver imaging techniques for intrahepatic metastatic nodules of hepatocellular carcinoma. Hepatology 1992; 16:694701.
  • 22
    Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334:693699.
  • 23
    Klintmalm GB. Liver transplantation for hepatocellular carcinoma. A registry report of the impact of tumor characteristics on outcome. Ann Surg 1998; 228:479490.
  • 24
    Wanebo HJ, Falkson G, Order S. Principles and Practice of Oncology. 3rd ed. Philadelphia: Lippincott; 1989:836.
  • 25
    Nerenstone SR, Ihde DC, Friedman MA. Clinical trials in primary hepatocellular carcinoma: Current status and future directions. Cancer Treat Rev 1988; 15:131.
  • 26
    Tsuzuki T, Sugioka A, Ueda M, Iida S, Kanai T, Yoshii H, Nakayasu K. Hepatic resection for hepatocellular carcinoma. Surgery 1990; 107:511520.
  • 27
    Herfarth C, Heuschen UA, Lamade W, Lehnert T, Otto G. Resections of recurrence in the liver of primary and secondary liver cancers. Chirurg 1995; 66:949958.
  • 28
    Iwatsuki S, Starzl TE. Personal experience with 411 hepatic resections. Ann Surg 1988; 208:421434.
  • 29
    Kinami Y, Takashima S, Miyazaki I. Hepatic resection for hepatocellular carcinoma associated with liver cirrhosis. World J Surg 1986; 10:294301.
  • 30
    Bismuth H, Houssin D, Ornowski J, Meriggi F. Liver resections in cirrhotic patients: A Western experience. World J Surg 1986; 10:311317.
  • 31
    Sesto ME, Vogt DP, Hermann RE. Hepatic resection in 128 patients: A 24-year experience. Surgery 1987; 102:846851.
  • 32
    Nagasue N, Yukaya H, Ogawa Y, Sasaki Y, Chang YC, Niimi K. Clinical experience with 118 hepatic resections for hepatocellular carcinoma. Surgery 1986; 99:694701.
  • 33
    Chen MF, Hwang TL, Jeng LB, Jan YY, Wang CS, Chou FF. Hepatic resection in 120 patients with hepatocellular carcinoma. Arch Surg 1989; 124:10251028.
  • 34
    Lai EC, Fan ST, Lo CM, Chu KM, Liu CL, Wong J. Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Ann Surg 1995; 221:291298.
  • 35
    Sugioka A, Tsuzuki T, Kanai T. Postresection prognosis of patients with hepatocellular carcinoma. Surgery 1993; 113:612618.
  • 36
    Nagao T, Inoue S, Goto S, Mizuta T, Omori Y, Kawano N, Morioka Y. Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis. Ann Surg 1987; 205:3340.
  • 37
    Ikeda K, Saitoh S, Tsubota A, Arase Y, Chayama K, Kumada H, et al. Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma. Cancer 1993; 71:1925.
  • 38
    Takenaka K, Kawahara N, Yamamoto K, Kajiyama K, Maeda T, Itasaka H, et al. Results of 280 liver resections for hepatocellular carcinoma. Arch Surg 1996; 131:7176.
  • 39
    Nagorney DM, van Heerden JA, Ilstrup DM, Adson MA. Primary hepatic malignancy: Surgical management and determinants of survival. Surgery 1989; 106:740748.
  • 40
    Vauthey JN, Klimstra D, Franceschi D, Tao Y, Fortner J, Blumgart L, Brennan M. Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg 1995; 169:2834.
  • 41
    Pichlmayr R, Ringe B, Bechstein WO, Lauchart W, Neuhaus P. Approach to primary liver cancer. Recent Results Cancer Res 1988; 110:6573.
  • 42
    Smalley SR, Moertel CG, Hilton JF, Weiland LH, Weiand HS, Adson MA, et al. Hepatoma in the noncirrhotic liver. Cancer 1988; 62:14141424.
  • 43
    Craig JR, Peters RL, Edmondson HA, Omata M. Fibrolamellar carcinoma of the liver: A tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer 1980; 46:372379.
  • 44
    Wood WJ, Rawlings M, Evans H, Lim CN. Hepatocellular carcinoma: Importance of histologic classification as a prognostic factor. Am J Surg 1988; 155:663666.
  • 45
    Starzl TE, Iwatsuki S, Shaw BW Jr, Nalesnik MA, Farhi DC, Van Thiel DH. Treatment of fibrolamellar hepatoma with partial or total hepatectomy and transplantation of the liver. Surg Gynecol Obstet 1986; 162:145148.
  • 46
    Fong Y, Sun RL, Jarnagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 1999; 229:790799.
  • 47
    Lai EC, Ng IO, Ng MM, Lok AS, Tam PC, Fan ST, et al. Long-term results of resection for large hepatocellular carcinoma: A multivariate analysis of clinicopathological features. Hepatology 1990; 11:815818.
  • 48
    Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann Surg 1990; 211:277287.
  • 49
    Nagorney DM, Adson MA, Weiland LH, Knight CD Jr, Smalley SR, Zinsmeister AR. Fibrolamellar hepatoma. Am J Surg 1985; 149:113119.
  • 50
    Roles DB. Fibrolamellar carcinoma of the liver. In: OkudaK, IshakKG, eds. Neoplasms of the Liver. Tokyo: Springer; 1987:137.
  • 51
    Starzl TE, Putnam CW. Experience in Hepatic Transplantation. Philadelphia: Saunders; 1969.
  • 52
    Macdougal BRD, Williams R. Indications and assessment for orthotopic liver transplantation. In: CalneRY ed. Liver Transplantation. London: Grune & Stratton; 1983:59.
  • 53
    Olthoff KM, Millis JM, Rosove MH, Goldstein LI, Ramming KP, Busuttil RW. Is liver transplantation justified for the treatment of hepatic malignancies? Arch Surg 1990; 125:12611266.
  • 54
    Pichlmayr R. Is there a place for liver grafting for malignancy? Transplant Proc 1988; 20:478482.
  • 55
    Hart J, Busuttil RW, Lewin KJ. Disease recurrence following liver transplantation. Am J Surg Pathol 1990; 14:7991.
  • 56
    Iwatsuki S, Gordon RD, Shaw BW Jr, Starzl TE. Role of liver transplantation in cancer therapy. Ann Surg 1985; 202:401407.
  • 57
    O'Grady JG, Polson RJ, Rolles K, Calne RY, Williams R. Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg 1988; 207:373379.
  • 58
    Ringe B, Wittekind C, Bechstein WO, Bunzendahl H, Pichlmayr R. The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence. Ann Surg 1989; 209:8898.
  • 59
    Jenkins RL, Pinson CW, Stone MD. Experience with transplantation in the treatment of liver cancer. Cancer Chemother Pharmacol 1989; 23:S104109.
  • 60
    Penn I. Hepatic transplantation for primary and metastatic cancers of the liver. Surgery 1991; 110:726734.
  • 61
    Busuttil RW, Farmer DG. The surgical treatment of primary hepatobiliary malignancy. Liver Transpl Surg 1996; 2:114130.
  • 62
    Farmer DG, Rosove MH, Shaked A, Busuttil RW. Current treatment modalities for hepatocellular carcinoma. Ann Surg 1994; 219:236247.
  • 63
    Yokoyama I, Todo S, Iwatsuki S, Starzl TE. Liver transplantation in the treatment of primary liver cancer. Hepatogastroenterology 1990; 37:188193.
  • 64
    Ismail T, Angrisani L, Gunson BK, Hubscher SG, Buckels JA, Neuberger JM, et al. Primary hepatic malignancy: The role of liver transplantation. Br J Surg 1990; 77:983987.
  • 65
    Pichlmayr R, Weimann A, Steinhoff G, Ringe B. Liver transplantation for hepatocellular carcinoma: Clinical results and future aspects. Cancer Chemother Pharmacol 1992; 31:S157161.
  • 66
    Haug CE, Jenkins RL, Rohrer RJ, Auchincloss H, Delmonico FL, Freeman RB, et al. Liver transplantation for primary hepatic cancer. Transplantation 1992; 53:376382.
  • 67
    Pichlmayr R, Weimann A, Ringe B. Indications for liver transplantation in hepatobiliary malignancy. Hepatology 1994; 20:33S40S.
  • 68
    Iwatsuki S, Starzl TE, Sheahan DG, Yokoyama I, Demetris AJ, Todo S, et al. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 1991; 214:221228.
  • 69
    Ringe B, Pichlmayr R, Wittekind C, Tusch G. Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients. World J Surg 1991; 15:270285.
  • 70
    Marsh JW, Dvorchik I, Subotin M, Balan V, Rakela J, Popechitelev EP, et al. The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: A pilot study. Hepatology 1997; 26:444450.
  • 71
    Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985; 56:918928.
  • 72
    Suarez Y, Franca AC, Llovet JM, Fuster J, Bruix J. The current status of liver transplantation for primary hepatic malignancy. Clin Liver Dis 2000; 4:591605.
  • 73
    Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: The BCLC staging classification. Semin Liver Dis 1999; 19:329338.
  • 74
    Bismuth H, Chiche L, Adam R, Castaing D, Diamond T, Dennison A. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 1993; 218:145151.
  • 75
    McPeake JR, O'Grady JG, Zaman S, Portmann B, Wight DG, Tan KC, et al. Liver transplantation for primary hepatocellular carcinoma: Tumor size and number determine outcome. J Hepatol 1993; 18:226234.
  • 76
    Selby R, Kadry Z, Carr B, Tzakis A, Madariaga JR, Iwatsuki S. Liver transplantation for hepatocellular carcinoma. World J Surg 1995; 19:5358.
  • 77
    Goldstein RM, Baker J, Testa G, Jennings LW, Brooks BK, Levy MF, et al. Total hepatectomy and liver transplantation for hepatocellular carcinoma. A single center experience with 72 patients. Presented at the 23rd Annual Scientific Meeting of the American Society of Transplant Surgeons, May 14–16, 1997, Chicago, IL.
  • 78
    Schlitt HJ, Neipp M, Weimann A, Oldhafer KJ, Schmoll E, Boeker K, et al. Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation. J Clin Oncol 1999; 17:324331.
  • 79
    Marsh JW, Dvorchik I, Bonham CA, Iwatsuki S. Is the pathologic TNM staging system for patients with hepatoma predictive of outcome? Cancer 2000; 88:538543.
  • 80
    American Joint Committee on Cancer: Liver (including intrahepatic bile ducts). In: BeahrsO, HensonD, HutterR, et al, eds. Manual for Staging of Cancer. Philadelphia: Lippincott; 1992:89.
  • 81
    Pichlmayr R, Ringe B, Wittekind C, Bunzendahl H, Gubernatis G, Grote R, et al. Liver grafting for malignant liver tumors. Transplant Proc 1989; 21:24032405.
  • 82
    Kar S, Carr BI. Detection of liver cells in peripheral blood of patients with advanced-stage hepatocellular carcinoma. Hepatology 1995; 21:403407.
  • 83
    Yokoyama I, Carr B, Saitsu H, Iwatsuki S, Starzl TE. Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation. Cancer 1991; 68:20952100.
  • 84
    Fruman DA, Klee CB, Bierer BE, Burakoff SJ. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A. Proc Natl Acad Sci U S A 1992; 89:36863690.
  • 85
    Reizenstein P, Ogier C, Blomgren H, Petrini B, Wasserman J. Cells responsible for tumor surveillance in man: Effects of radiotherapy, chemotherapy, and biologic response modifiers. Adv Immun Cancer Ther 1985; 1:128.
  • 86
    Bismuth H, Farges O, Castaing D, Samuel D, Adam R, Johann M, et al. Evaluation of results of liver transplantation: Experience based on a series of 1052 transplantations. Presse Med 1995; 24:11061114.
  • 87
    Iwatsuki S, Marsh JW, Starzl TE. Survival after liver transplantation in patients with hepatocellular carcinoma. Princess Takamatsu Symp 1995; 25:271276.
  • 88
    Olthoff KM, Rosove MH, Shackleton CR, Imagawa DK, Farmer DG, Northcross P, et al. Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma. Ann Surg 1995; 221:734741.
  • 89
    Stone MJ, Klintmalm G, Polter D, Husberg B, Egorin MJ. Neoadjuvant chemotherapy and orthotopic liver transplantation for hepatocellular carcinoma. Transplantation 1989; 48:344347.
  • 90
    Schwartz ME, Sung M, Mor E, Fisher A, Popescu I, Fiel I, et al. A multidisciplinary approach to hepatocellular carcinoma in patients with cirrhosis. J Am Coll Surg 1995; 180:596603.
  • 91
    Tan KC, Rela M, Ryder SD, Rizzi PM, Karani J, Portmann B, et al. Experience of orthotopic liver transplantation and hepatic resection for hepatocellular carcinoma of less than 8 cm in patients with cirrhosis. Br J Surg 1995; 82:253256.
  • 92
    Ferris JV, Baron RL, Marsh JW Jr, Oliver JH 3rd, Carr BI, Dodd GD 3rd. Recurrent hepatocellular carcinoma after liver transplantation: Spectrum of CT findings and recurrence patterns. Radiology 1996; 198:233238.
  • 93
    Pichlmayr R, Weimann A, Tusch G, Schlitt HJ. Indications and role of liver transplantation for malignant tumors. Oncologist 1997; 2:164170.
  • 94
    Pinna AD, Iwatsuki S, Lee RG, Todo S, Madariaga JR, Marsh JW, et al. Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation. Hepatology 1997; 26:877883.
  • 95
    Achkar JP, Araya V, Baron RL, Marsh JW, Dvorchik I, Rakela J. Undetected hepatocellular carcinoma: Clinical features and outcome after liver transplantation. Liver Transpl Surg 1998; 4:477482.
  • 96
    Otto G, Heuschen U, Hofmann WJ, Krumm G, Hinz U, Herfarth C. Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma: A retrospective analysis. Ann Surg 1998; 227:424432.
  • 97
    Pichlmayr R, Weimann A, Oldhafer KJ, Schlitt HJ, Tusch G, Raab R. Appraisal of transplantation for malignant tumours of the liver with special reference to early stage hepatocellular carcinoma. Eur J Surg Oncol 1998; 24:6067.
  • 98
    Sarasin FP, Giostra E, Mentha G, Hadengue A. Partial hepatectomy or orthotopic liver transplantation for the treatment of resectable hepatocellular carcinoma? A cost-effectiveness perspective. Hepatology 1998; 28:436442.
  • 99
    Van Thiel DH, Colantoni A, De Maria N. Liver transplantation for hepatocellular carcinoma? Hepatogastroenterology 1998; 45:19441949.
  • 100
    Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, et al. Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33:13941403.
  • 101
    Kirimlioglu H, Dvorchick I, Ruppert K, Finkelstein S, Marsh JW, Iwatsuki S, et al. Hepatocellular carcinomas in native livers from patients treated with orthotopic liver transplantation: Biologic and therapeutic implications. Hepatology 2001; 34:502510.
  • 102
    Annual Report of the US Scientific Registry for Organ Transplantation and the Organ Procurement and Transplantation Data—Transplant Data: 1998–1996. UNOS, Richmond, VA, and the Division of Transplantation, Bureau of Health Resources and Services Administration, US Department of Health and Human Services, Rockville, MD, 1996.
  • 103
    Schmidt HH, Nashan B, Propsting MJ, Nakazato M, Flemming P, Kubicka S, et al. Familial amyloidotic polyneuropathy: Domino liver transplantation. J Hepatol 1999; 30:293298.
  • 104
    Majno PE, Sarasin FP, Mentha G, Hadengue A. Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: An outcome-oriented decision analysis. Hepatology 2000; 31:899906.
  • 105
    Goldstein R, Molmenti EP, Orr D, Meyer R, Derrick H, Westmoreland M, Levy M, Klintmalm G. Treatment of hepatomas in cirrhotic patients with radiofrequency thermal ablation [abstract]. Liver Transpl 2000; 6:C3.
  • 106
    Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS. Small hepatocellular carcinoma: Treatment with radio-frequency ablation versus ethanol injection. Radiology 1999; 210:655661.
  • 107
    Rossi S, Garbagnati F, Lencioni R, Allgaier HP, Marchiano A, Fornari F, et al. Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology 2000; 217:119126.
  • 108
    Ravikumar TS, Kane R, Cady B, Jenkins R, Clouse M, Steele G, Jr. A 5-year study of cryosurgery in the treatment of liver tumors. Arch Surg 1991; 126:15201523.
  • 109
    Adam R, Akpinar E, Johann M, Kunstlinger F, Majno P, Bismuth H. Place of cryosurgery in the treatment of malignant liver tumors. Ann Surg 1997; 225:3948.
  • 110
    Liu CL, Fan ST. Nonresectional therapies for hepatocellular carcinoma. Am J Surg 1997; 173:358365.
  • 111
    Schafer DF, Sorrell MF. Hepatocellular carcinoma. Lancet 1999; 353:12531257.
  • 112
    Vogl TJ, Trapp M, Schroeder H, Mack M, Schuster A, Schmitt J, et al. Transarterial chemoembolization for hepatocellular carcinoma: Volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center. Radiology 2000; 214:349357.
  • 113
    Harnois DM, Steers J, Andrews JC, Rubin JC, Pitot HC, Burgart L, et al. Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma. Liver Transpl Surg 1999; 5:192199.
  • 114
    Louha M, Poussin K, Ganne N, Zylberberg H, Nalpas B, Nicolet J, et al. Spontaneous and iatrogenic spreading of liver-derived cells into peripheral blood of patients with primary liver cancer. Hepatology 1997; 26:9981005.
  • 115
    Oldhafer KJ, Chavan A, Fruhauf NR, Flemming P, Schlitt HJ, Kubicka S, et al. Arterial chemoembolization before liver transplantation in patients with hepatocellular carcinoma: Marked tumor necrosis, but no survival benefit? J Hepatol 1998; 29:953959.
  • 116
    Falkson G, Coetzer B. Chemotherapy of primary liver cancer. In: OkudaK, IshakKG, eds. Neoplasms of the Liver. Tokyo: Springer; 1987:320.
  • 117
    Nakashima T. Vascular changes and hemodynamics in hepatocellular carcinoma. In: OkudaK, PetersRL, eds. Hepatocellular Carcinoma. New York: Wiley; 1976:169.
  • 118
    Hemming AW, Cattral MS, Reed AI, Van der Werf WJ, Greig PD, Howard RJ. Liver transplantation for hepatocellular carcinoma. Ann Surg 2001; 233:652659.
  • 119
    Schwarz KB, Kew M, Klein A, Abrams RA, Sitzmann J, Jones L, et al. Increased hepatic oxidative DNA damage in patients with hepatocellular carcinoma. Dig Dis Sci 2001; 46:21732178.